BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lamba G, Gupta R, Lee B, Ambrale S, Liu D. Current management and prognostic features for gastrointestinal stromal tumor (GIST). Exp Hematol Oncol. 2012;1:14. [PMID: 23210689 DOI: 10.1186/2162-3619-1-14] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Michael O, Derick K, Ponsiano O. Gastroduodenal intussusception as a rare cause of pancreatitis in a young female Ugandan: A case report. Int J Surg Case Rep 2021;89:106632. [PMID: 34844196 DOI: 10.1016/j.ijscr.2021.106632] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Tada Y, Yamamoto M, Sawata S, Hara K, Sugesawa K, Ueshima C, Tanio A, Kihara K, Matsunaga T, Tokuyasu N, Takano S, Sakamoto T, Honjo S, Hasegawa T, Fujiwara Y. Ruptured Small Intestinal Stromal Tumor Causing Concurrent Gastrointestinal and Intra-Abdominal Hemorrhage: A Case Report. Yonago Acta Med 2021;64:137-42. [PMID: 33642915 DOI: 10.33160/yam.2021.02.019] [Reference Citation Analysis]
3 Ma XB, Liu LJ, Niu Q, Shang BY, Li YY, Liu CX. Multiple intestinal stromal tumors in a young patient with acute gastrointestinal hemorrhage: A case report and literature review. Shijie Huaren Xiaohua Zazhi 2019; 27(15): 972-976 [DOI: 10.11569/wcjd.v27.i15.972] [Reference Citation Analysis]
4 Yang DY, Wang X, Yuan WJ, Chen ZH. Metastatic pattern and prognosis of gastrointestinal stromal tumor (GIST): a SEER-based analysis. Clin Transl Oncol. 2019;21:1654-1662. [PMID: 30905025 DOI: 10.1007/s12094-019-02094-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
5 Krishnamurthy G, Singh H, Sharma V, Savlania A, Vasishta RK. Therapeutic Challenges in the Management of Bleeding Duodenal Gastrointestinal Stromal Tumor: a Case Report and Review of Literature. J Gastrointest Canc 2019;50:170-4. [DOI: 10.1007/s12029-018-00197-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Inaba CS, Dosch A, Koh CY, Sujatha-bhaskar S, Pejcinovska M, Smith BR, Nguyen NT. Laparoscopic versus open resection of gastrointestinal stromal tumors: survival outcomes from the NCDB. Surg Endosc 2019;33:923-32. [DOI: 10.1007/s00464-018-6393-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
7 Al Momani LA, Abughanimeh O, Shipley LC, Phemister J, Swenson J, Young M. Recurrent Gastric Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis. Cureus. 2018;10:e2854. [PMID: 30148007 DOI: 10.7759/cureus.2854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Moura DS, Ramos R, Fernandez-Serra A, Serrano T, Cruz J, Alvarez-Alegret R, Ortiz-Duran R, Vicioso L, Gomez-Dorronsoro ML, Garcia Del Muro X, Martinez-Trufero J, Rubio-Casadevall J, Sevilla I, Lainez N, Gutierrez A, Serrano C, Lopez-Alvarez M, Hindi N, Taron M, López-Guerrero JA, Martin-Broto J. Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients. Oncotarget 2018;9:17576-88. [PMID: 29707131 DOI: 10.18632/oncotarget.24799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Efared B, Atsame-Ebang G, Tahiri L, Sidibé IS, Erregad F, Hammas N, Arifi S, Mellouki I, Ousadden A, Mazaz K, El Fatemi H, Chbani L. The expression of MDM2 in gastrointestinal stromal tumors: immunohistochemical analysis of 35 cases. BMC Clin Pathol 2018;18:2. [PMID: 29410603 DOI: 10.1186/s12907-018-0069-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Huang Y, Zhao R, Cui Y, Wang Y, Xia L, Chen Y, Zhou Y, Wu X. Effect of Gastrointestinal Bleeding on Gastrointestinal Stromal Tumor Patients: A Retrospective Cohort Study. Med Sci Monit 2018;24:363-9. [PMID: 29346334 DOI: 10.12659/msm.908186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
11 Grossi U, Ardito F, Petracca Ciavarella L, Goglia M, Giuliante F. Ultra-late recurrence of gastrointestinal stromal tumour: case report and literature review. ANZ J Surg 2019;89:E224-5. [PMID: 29194890 DOI: 10.1111/ans.14286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Machairas N, Prodromidou A, Molmenti E, Kostakis ID, Sotiropoulos GC. Management of liver metastases from gastrointestinal stromal tumors: where do we stand? J Gastrointest Oncol. 2017;8:1100-1108. [PMID: 29299371 DOI: 10.21037/jgo.2017.08.08] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang J, Wu J, Hong C, Wang Y, Zhou Y, Long Z, Zhou Y, Qin H. Involvement of Bmi-1 gene in the development of gastrointestinal stromal tumor by regulating p16 Ink4A /p14 ARF gene expressions: An in vivo and in vitro study. Pathology - Research and Practice 2017;213:1542-51. [DOI: 10.1016/j.prp.2017.09.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
14 Qiu G, Wang J, Che X, He S, Wei C, Li X, Pang K, Fan L. Laparoscopic Versus Open Resection of Gastric Gastrointestinal Stromal Tumors Larger Than 5 cm: A Single-Center, Retrospective Study. Surg Innov. 2017;24:582-589. [PMID: 28933252 DOI: 10.1177/1553350617731402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
15 Porter MG, Stoeger SM. Atypical Colorectal Neoplasms. Surgical Clinics of North America 2017;97:641-56. [DOI: 10.1016/j.suc.2017.01.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
16 Yin Z, Gao J, Liu W, Huang C, Shuai X, Wang G, Tao K, Zhang P. Clinicopathological and Prognostic Analysis of Primary Gastrointestinal Stromal Tumor Presenting with Gastrointestinal Bleeding: a 10-Year Retrospective Study.J Gastrointest Surg. 2017;21:792-800. [PMID: 28275959 DOI: 10.1007/s11605-017-3385-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
17 Carlson J, Alobuia W, Mizell J. Rectal gastrointestinal stromal tumor with metastasis to the penis: Case report and review of literature. Int J Surg Case Rep 2016;29:172-5. [PMID: 27865145 DOI: 10.1016/j.ijscr.2016.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Mastoraki A, Toliaki E, Chrisovergi E, Mastoraki S, Papanikolaou IS, Danias N, Smyrniotis V, Arkadopoulos N. Metastatic Liver Disease Associated with Gastrointestinal Stromal Tumors: Controversies in Diagnostic and Therapeutic Approach. J Gastrointest Cancer 2015;46:237-42. [PMID: 26163021 DOI: 10.1007/s12029-015-9748-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
19 Zhao H, Zhu H, Jin Q, Zhang S, Wang W, Wang D, Huang J. Association of high expression of Groβ with clinical and pathological characteristics of unfavorable prognosis in gastrointestinal stromal tumors. Dis Markers 2015;2015:171035. [PMID: 25944970 DOI: 10.1155/2015/171035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
20 Willingham FF, Reynolds P, Lewis M, Ross A, Maithel SK, Rocha FG. Hybrid push-pull endoscopic and laparoscopic full thickness resection for the minimally invasive management of gastrointestinal stromal tumors: a pilot clinical study. Gastroenterol Res Pract. 2015;2015:618756. [PMID: 25945087 DOI: 10.1155/2015/618756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Poveda A, del Muro XG, López-Guerrero JA, Martínez V, Romero I, Valverde C, Cubedo R, Martín-Broto J. GEIS 2013 guidelines for gastrointestinal sarcomas (GIST). Cancer Chemother Pharmacol. 2014;74:883-898. [PMID: 25193432 DOI: 10.1007/s00280-014-2547-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
22 Loewen G, Zhuo Y, Zhuang Y, Jayawickramarajah J, Shan B. lincRNA HOTAIR as a novel promoter of cancer progression. J Can Res Updates 2014;3:134-40. [PMID: 25663954 DOI: 10.6000/1929-2279.2014.03.03.3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
23 Lyseng-Williamson KA. Regorafenib: a guide to its use in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib and sunitinib. BioDrugs 2013;27:525-31. [PMID: 23975637 DOI: 10.1007/s40259-013-0061-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
24 Pawar R, Bali OP, Malhotra BK, Lamba G. Recent advances and novel agents for FLT3 mutated acute myeloid leukemia. Stem Cell Investig 2014;1:7. [PMID: 27358854 DOI: 10.3978/j.issn.2306-9759.2014.03.03] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
25 Errasti Alustiza J, Espín Basany E, Reina Duarte A. Rare tumors of the rectum. Narrative review. Cir Esp 2014;92:579-88. [PMID: 24629769 DOI: 10.1016/j.ciresp.2013.06.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
26 Mansoor E. Multifocal small bowel stromal tumours presenting with peritonitis in an HIV positive patient. Int J Surg Case Rep 2014;5:243-5. [PMID: 24705193 DOI: 10.1016/j.ijscr.2014.03.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
27 Furqan M, Akinleye A, Mukhi N, Mittal V, Chen Y, Liu D. STAT inhibitors for cancer therapy. J Hematol Oncol 2013;6:90. [PMID: 24308725 DOI: 10.1186/1756-8722-6-90] [Cited by in Crossref: 116] [Cited by in F6Publishing: 124] [Article Influence: 12.9] [Reference Citation Analysis]
28 Yang W, Diamond AM. Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome. Biomark Res. 2013;1:15. [PMID: 24163737 DOI: 10.1186/2050-7771-1-15] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
29 Kubota D, Yoshida A, Tsuda H, Suehara Y, Okubo T, Saito T, Orita H, Sato K, Taguchi T, Yao T. Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor. PLoS One. 2013;8:e73896. [PMID: 23977394 DOI: 10.1371/journal.pone.0073896] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
30 Reichardt P, Joensuu H, Blay JY. New fronts in the adjuvant treatment of GIST. Cancer Chemother Pharmacol. 2013;72:715-723. [PMID: 23934322 DOI: 10.1007/s00280-013-2248-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
31 Nannini M, Biasco G, Astolfi A, Pantaleo MA. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST). J Med Genet 2013;50:653-61. [DOI: 10.1136/jmedgenet-2013-101695] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 6.8] [Reference Citation Analysis]
32 Akinleye A, Furqan M, Mukhi N, Ravella P, Liu D. MEK and the inhibitors: from bench to bedside. J Hematol Oncol. 2013;6:27. [PMID: 23587417 DOI: 10.1186/1756-8722-6-27] [Cited by in Crossref: 170] [Cited by in F6Publishing: 170] [Article Influence: 18.9] [Reference Citation Analysis]
33 Xu X, Wang BM, Yu QX, Sun C. Expression of transient receptor potential channels and cholinergic muscarinic acetylcholine receptors in human gastrointestinal stromal tumors. Shijie Huaren Xiaohua Zazhi 2013; 21(10): 845-850 [DOI: 10.11569/wcjd.v21.i10.845] [Reference Citation Analysis]
34 Liu K, Cang S, Ma Y, Chiao JW. Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cells. Cancer Cell Int 2013;13:10. [PMID: 23388416 DOI: 10.1186/1475-2867-13-10] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
35 Bi X, Pohl N, Dong H, Yang W. Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice. J Hematol Oncol 2013;6:8. [PMID: 23327547 DOI: 10.1186/1756-8722-6-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
36 Hsueh CT, Liu D, Wang H. Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials. Biomark Res 2013;1:1. [PMID: 24252729 DOI: 10.1186/2050-7771-1-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
37 Chi A, Nguyen NP, Tse W, Sobremonte G, Concannon P, Zhu A. Intensity modulated radiotherapy for sinonasal malignancies with a focus on optic pathway preservation. J Hematol Oncol 2013;6:4. [PMID: 23294673 DOI: 10.1186/1756-8722-6-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
38 Huang X, Du X, Li Y. The role of BCL11B in hematological malignancy. Exp Hematol Oncol 2012;1:22. [PMID: 23211040 DOI: 10.1186/2162-3619-1-22] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]